Dujari Shefali, Wei Janet, Kraler Lironn, Goyal Tarini, Bernier Eric, Schwartz Neil, Hirsch Karen, Gold Carl A
Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.
Stanford Health Care, Stanford, CA, USA.
Neurohospitalist. 2023 Oct;13(4):337-344. doi: 10.1177/19418744231174577. Epub 2023 May 10.
The Neurology Mortality Review Committee at our institution identified variability in location of death for patients on our inpatient neurology services. Hospice may increase the number of patients dying in their preferred locations. This study aimed to characterize patients who die on inpatient neurology services and explore barriers to discharge to hospice.
This retrospective study was completed at a single, quaternary care medical center that is a Level I Trauma Center and Comprehensive Stroke Center. Patients discharged by an inpatient neurology service between 6/2019-1/2021 were identified and electronic medical record review was performed on patients who died in the hospital and who were discharged to hospice.
69 inpatient deaths and 74 discharges to hospice occurred during the study period. Of the 69 deaths, 54 occurred following withdrawal of life sustaining treatment (WLST), of which 14 had a referral to hospice placed. There were 88 "hospice-referred" patients and 40 "hospice-eligible" patients. Hospice-referred patients were less likely to require the intensive care unit than hospice-eligible patients. Hospice-referred patients had their code status changed to Do Not Intubate earlier and were more likely to have advanced directives available.
Our data highlight opportunities for further research to improve discharge to hospice including interhospital transfers, advanced directives, earlier goals of care discussions, palliative care consultations, and increased hospice bed availability. Importantly, it highlights the limitations of using in-hospital mortality as a quality indicator in this patient population.
我们机构的神经病学死亡率审查委员会发现,住院神经病学服务患者的死亡地点存在差异。临终关怀可能会增加在患者首选地点死亡的人数。本研究旨在描述在住院神经病学服务中死亡的患者特征,并探讨转至临终关怀的障碍。
这项回顾性研究在一家单一的四级医疗中心完成,该中心是一级创伤中心和综合卒中中心。确定了2019年6月至2021年1月期间由住院神经病学服务出院的患者,并对在医院死亡和转至临终关怀的患者进行了电子病历审查。
在研究期间,发生了69例住院死亡和74例转至临终关怀的情况。在69例死亡中,54例发生在维持生命治疗撤除(WLST)之后,其中14例已转诊至临终关怀。有88例“转诊至临终关怀”的患者和40例“符合临终关怀条件”的患者。转诊至临终关怀的患者比符合临终关怀条件的患者需要重症监护病房的可能性更小。转诊至临终关怀的患者更早将其代码状态改为“不要插管”,并且更有可能有预先指示。
我们的数据突出了进一步研究以改善转至临终关怀的机会,包括医院间转诊、预先指示、更早的护理目标讨论、姑息治疗咨询以及增加临终关怀床位的可用性。重要的是,它突出了将医院内死亡率用作该患者群体质量指标的局限性。